Want to join the conversation?
$AGN will also pay Akarna potential clinical, regulatory and commercial milestone payments related to AKN-083, its lead development compound. AKN-083 is in development for treating Non-Alcoholic Steatohepatitis, a severe type of non-alcoholic fatty liver disease.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.